CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / August 15, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today named …
Jetzt den vollständigen Artikel lesen